BillionToOne, Inc. Class A Common Stock (BLLN) - Total Liabilities
Based on the latest financial reports, BillionToOne, Inc. Class A Common Stock (BLLN) has total liabilities worth $192.89 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See BillionToOne, Inc. Class A Common Stock (BLLN) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
BillionToOne, Inc. Class A Common Stock - Total Liabilities Trend (2023–2025)
This chart illustrates how BillionToOne, Inc. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BillionToOne, Inc. Class A Common Stock (BLLN) total assets.
BillionToOne, Inc. Class A Common Stock Competitors by Total Liabilities
The table below lists competitors of BillionToOne, Inc. Class A Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
California Resources Corp
NYSE:CRC
|
USA | $3.70 Billion |
|
Louisiana-Pacific Corporation
NYSE:LPX
|
USA | $863.00 Million |
|
Shenzhen Everwin Precision Tech
SHE:300115
|
China | CN¥18.54 Billion |
|
Methanex Corporation
TO:MX
|
Canada | CA$4.29 Billion |
|
Hongda
SHG:600331
|
China | CN¥587.78 Million |
|
Hannon Armstrong Sustainable Infrastructure Capital Inc
NYSE:HASI
|
USA | $5.67 Billion |
|
Guoyuan Securities Co Ltd
SHE:000728
|
China | CN¥147.32 Billion |
|
Tamarack Valley Energy Ltd
TO:TVE
|
Canada | CA$1.64 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down BillionToOne, Inc. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BillionToOne, Inc. Class A Common Stock balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 11.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BillionToOne, Inc. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BillionToOne, Inc. Class A Common Stock (2023–2025)
The table below shows the annual total liabilities of BillionToOne, Inc. Class A Common Stock from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $152.55 Million | +13.58% |
| 2024-12-31 | $134.31 Million | -16.69% |
| 2023-12-31 | $161.20 Million | -- |
About BillionToOne, Inc. Class A Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, an… Read more